Ltm. Vanderven et al., HISTAMINE-STIMULATED EXPRESSION OF INSULIN-LIKE GROWTH-FACTORS IN HUMAN GLIOMA-CELLS, British Journal of Cancer, 75(8), 1997, pp. 1091-1097
Glioma tumour growth is associated with the expression of insulin-like
growth factors I and II (IGFs) and of both type I and type II IGF rec
eptors. It has also been shown that IGFs can stimulate proliferation o
f cultured glioma cells. We previously reported that histamine too can
stimulate the growth of glioma cells in vitro. In this report, we stu
dy whether the histamine-induced growth of G47 glioma cells is mediate
d by the IGFs. We found that histamine stimulates the expression of bo
th IGF-I and IGF-II mRNAs, as determined by a semiquantitative in situ
hybridization analysis. Furthermore, incubation of G47 cells with his
tamine also induced cellular immunostaining for IGF-II. It could be sh
own that IGF-I-stimulated proliferation is inhibited by IGFBP-3, which
decreases the availability of IGFs for binding to the IGF receptors,
and by beta-galactosidase, which may decrease IGF binding to the type
II IGF receptor, but is not inhibited by the anti-type I IGF receptor
monoclonal antibody alpha IR3. However, neither IGFBP-3 nor beta-galac
tosidase nor alpha IR3 inhibited the histamine-induced proliferation.
These results show that : the growth-stimulatory effect of histamine i
s accompanied by the induction of IGFs. This histamine-induced growth
stimulation is not mediated by activation of cell surface IGF receptor
s, although intracrine activation of type II IGF receptors may be invo
lved.